logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

C₂N Diagnostics, LLC raised $15M in an investment from Eisai Inc. to scale up and provide broad access to its Precivity™ tests for Alzheimer’s disease pathology

Mar 06, 2024•almost 2 years ago

Amount Raised

$15 Million

St. LouisBiotechnologyHealth Care

Investors

Eisai Inc.

Description

C₂N Diagnostics, LLC has announced an investment of up to 15 million USD from Eisai Inc. The investment aims to scale up and provide broad access to its Precivity™ tests for patients with cognitive impairment, helping healthcare providers determine Alzheimer’s disease pathology, and aid in medical management and treatment decisions.

Company Information

Company

C2N Diagnostics

Location

St. Louis, Missouri, United States

About

C2N Diagnostics is a company focused on developing advanced diagnostic solutions in the field of brain health, particularly in the early diagnosis and treatment of Alzheimer's disease.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech